- Home
- SILC vs NVCT Comparison
SILC vs NVCT Comparison
Compare SILC & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SILC | NVCT |
|---|---|---|
| Founded | 1987 | 2020 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 259.1M | 274.5M |
| IPO Year | 2002 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SILC | NVCT |
|---|---|---|
| Price | $46.60 | $13.73 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 134.6K | 93.6K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $17.17 | N/A |
| Revenue Next Year | $12.28 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.34 | $5.55 |
| 52 Week High | $52.58 | $14.16 |
Technical Indicators
Market Signals| Indicator | SILC | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 56.76 | 78.38 |
| Support Level | $16.31 | $5.70 |
| Resistance Level | $50.75 | N/A |
| Average True Range (ATR) | 4.55 | 0.64 |
| MACD | -0.13 | 0.36 |
| Stochastic Oscillator | 77.76 | 93.12 |
Price Performance
Historical ComparisonAbout SILC Silicom Ltd
Silicom Ltd is engaged in designing, manufacturing, marketing, and supporting high-performance networking and data infrastructure solutions for a broad range of servers, server-based systems, and communications devices. Its product categories consist of Server Adapters, Edge Networking Solutions, Switches, Edge AI Solutions, Edge Networking Accessories, 4G 5G Products, FPGA-Based Cards, and Others. Its geographic areas are the USA, North America - other, Israel, Europe, and Asia-Pacific. It derives a majority of its revenue from the USA.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.